| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 8,009,000 | 7,852,000 | 8,137,000 | 9,538,000 | | Cost of Revenue | 6,076,000 | 5,803,000 | 7,226,000 | 5,865,000 | | | Gross Profit | 1,933,000 | 2,049,000 | 911,000 | 3,673,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,123,000 | 1,198,000 | 233,000 | 2,398,000 | | Non Recurring |
-
| 1,204,000 |
-
|
-
| | Others | 495,000 | 496,000 | 496,000 | 491,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 315,000 | (849,000) | 182,000 | 784,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,000) | 22,000 | (4,000) |
-
| | Earnings Before Interest And Taxes | 312,000 | (827,000) | 178,000 | 784,000 | | Interest Expense | 18,000 | 47,000 | 19,000 | 10,000 | | Income Before Tax | 294,000 | (874,000) | 159,000 | 774,000 | | Income Tax Expense | 113,000 | 2,000 | 62,000 | 281,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 181,000 | (876,000) | 97,000 | 493,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 181,000 | (876,000) | 97,000 | 493,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $181,000 | ($876,000) | $97,000 | $493,000 |
|
0.22% Nasdaq 0.00%
Income Statement
